Augmentation of neovascularization in murine hindlimb ischemia by combined therapy with simvastatin and bone marrow-derived mesenchymal stem cells transplantation

OBJECTIVES: We postulated that combining high-dose simvastatin with bone marrow derived-mesenchymal stem cells (MSCs) delivery may give better prognosis in a mouse hindlimb ischemia model. METHODS: Mouse hindlimb ischemia model was established by ligating the right femoral artery. Animals were group...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yong, Zhang, Dingguo, Zhang, Yuqing, He, Guoping, Zhang, Fumin
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2946286/
https://www.ncbi.nlm.nih.gov/pubmed/20846454
http://dx.doi.org/10.1186/1423-0127-17-75

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2946286/
https://www.ncbi.nlm.nih.gov/pubmed/20846454
http://dx.doi.org/10.1186/1423-0127-17-75

Ejemplares similares